Last news
Coloplast A/S - Allocation of Share Options

Coloplast A/S - Allocation of Share Options

Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market......

Regarding the publication of LITGRID AB interim information

Regarding the publication of LITGRID AB interim information

In 2023 LITGRID AB (company code 302564383, registered office at Karlo Gustavo Emilio Manerheimo Str. 8, Vilnius) financial results will be released......

Vivoryon Therapeutics N.V. to Present at the 2023 BIO CEO &

Vivoryon Therapeutics N.V. to Present at the 2023 BIO CEO &

Vivoryon Therapeutics N.V. to Present at the 2023 BIO CEO & Investor Conference Halle (Saale) / Munich, Germany, February 3, 2022 – Vivoryon......

Top Skateboarders Converge on Sharjah UAE for World

Top Skateboarders Converge on Sharjah UAE for World

California Skateparks-designed Aljada Skatepark hosts world's best on their road to Paris.......

Stellantis to Announce Full Year 2022 Results on February

Stellantis to Announce Full Year 2022 Results on February

Stellantis to Announce Full Year 2022 Results on February 22 AMSTERDAM, February 3, 2023 - Stellantis N.V. announced today that its Full Year 2022......

Bergman & Beving acquires A.T.E. Solutions

Bergman & Beving acquires A.T.E. Solutions

Press release Bergman & Beving acquires A.T.E. Solutions Bergman & Beving has today acquired A.T.E. Solutions Ltd. A.T.E produce and......

Monte Rosa Therapeutics to Present at Upcoming Investor

Monte Rosa Therapeutics to Present at Upcoming Investor

BOSTON, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology company developing novel molecular glue degrader......

1 ... 597 598 599 600 601 602 603 604 605 ... 663
menu
menu